Skip to Main Content

Paper Details

Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016.
Transfusion
24
2018
Human, RBC, red blood cell, red blood cell product
Adult, Animals, Biological Products, Blood Preservation, Blood Safety, Child, Erythrocyte Transfusion, Erythrocytes, Humans, Models, Animal, Randomized Controlled Trials as Topic, Transfusion Reaction, United States, United States Food and Drug Administration
Author NameAffiliation
Jaroslav G Vostal
Paul W Buehler
Monique P Gelderman
Abdu I Alayash
Allan DoctorSt Louis Children's Hospital
James C Zimring
Simone A Glynn
John R HessUniversity of Washington
Harvey G KleinNational Institutes of Health, Clinical Center
Jason P Acker
Philip C SpinellaWashington University School of Medicine
Angelo D'AlessandroUniversity of Colorado-Anschutz Medical Campus
Angelo D'AlessandroUniversity of Colorado-Anschutz Medical Campus
Bernhard O PalssonCenter for Systems Biology, University of Iceland
Bernhard O PalssonCenter for Systems Biology, University of Iceland
Thomas J RaifeUniversity of Wisconsin-Madison
Michael P BuschBlood Systems Research Institute
Timothy J McMahonDuke University Medical Center, and the Durham VA Medical Center
Marcos IntagliettaUniversity of California at San Diego
Marcos IntagliettaUniversity of California at San Diego
Harold M SwartzDartmouth College Geisel School of Medicine
Michael A DubickUS Army Institute of Surgical Research
Sylvain CardinNaval Medical Research Unit-San Antonio
Rakesh P PatelCenter for Free Radical Biology and Translational and Molecular Sciences Certificate Program, University of Alabama
Charles NatansonNIH Clinical Center
John W WeiselPerelman School of Medicine, University of Pennsylvania
Jennifer A MuszynskiThe Ohio State University College of Medicine
Philip J NorrisBlood Systems Research Institute, Inc.
Paul M NessJohns Hopkins University School of Medicine
  • 1 - 29

Datasets

Release 1.2